264 related articles for article (PubMed ID: 8865529)
1. Coagulation activation and fibrinolytic imbalance in subjects with idiopathic antiphospholipid antibodies--a crucial role for acquired free protein S deficiency.
Ames PR; Tommasino C; Iannaccone L; Brillante M; Cimino R; Brancaccio V
Thromb Haemost; 1996 Aug; 76(2):190-4. PubMed ID: 8865529
[TBL] [Abstract][Full Text] [Related]
2. Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus.
Ginsberg JS; Demers C; Brill-Edwards P; Bona R; Johnston M; Wong A; Denburg JA
Am J Med; 1995 Apr; 98(4):379-83. PubMed ID: 7709951
[TBL] [Abstract][Full Text] [Related]
3. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
[TBL] [Abstract][Full Text] [Related]
4. Free protein S deficiency may be found in patients with antiphospholipid antibodies who do not have systemic lupus erythematosus.
Crowther MA; Johnston M; Weitz J; Ginsberg JS
Thromb Haemost; 1996 Nov; 76(5):689-91. PubMed ID: 8950774
[TBL] [Abstract][Full Text] [Related]
5. Differences in protein S and C4b-binding protein levels in different groups of patients with antiphospholipid antibodies.
Forastiero RR; Kordich L; Basilotta E; Carreras LO
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):609-16. PubMed ID: 7841319
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
[TBL] [Abstract][Full Text] [Related]
8. Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.
Gschwandtner ME; Eichinger S; Hütter D; Korninger L; Lechner K; Panzer S; Pabinger I
Blood Coagul Fibrinolysis; 1996 Apr; 7(3):325-30. PubMed ID: 8735139
[TBL] [Abstract][Full Text] [Related]
9. [Prothrombotic state in early stages of chronic Chagas' disease. Its association with thrombotic risk factors].
Herrera RN; Díaz E; Pérez Aguilar R; Bianchi J; Berman S; Luciardi HL
Arch Cardiol Mex; 2005; 75 Suppl 3():S3-38-48. PubMed ID: 16366168
[TBL] [Abstract][Full Text] [Related]
10. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Vassiliadis T; Mpoumponaris A; Giouleme O; Evgenidis N
Med Sci Monit; 2009 Nov; 15(11):CR563-72. PubMed ID: 19865055
[TBL] [Abstract][Full Text] [Related]
11. [Anomalies of coagulation and fibrinolytic activity in patients with chronic pulmonary thromboembolism].
Aiello E; Presbitero P; Stella S; Borchiellini A; Garis G; Bazzan M; Schinco P; Tamponi G
G Ital Cardiol; 1993 Apr; 23(4):345-51. PubMed ID: 8319862
[TBL] [Abstract][Full Text] [Related]
12. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of antiphospholipid antibodies].
Atsumi T; Koike T
Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
[TBL] [Abstract][Full Text] [Related]
15. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
[TBL] [Abstract][Full Text] [Related]
16. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation.
Sakai Y; Atsumi T; Ieko M; Amengual O; Furukawa S; Furusaki A; Bohgaki M; Kataoka H; Horita T; Yasuda S; Koike T
Arthritis Rheum; 2009 Aug; 60(8):2457-67. PubMed ID: 19644870
[TBL] [Abstract][Full Text] [Related]
17. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
Sanmarco M; Gayet S; Alessi MC; Audrain M; de Maistre E; Gris JC; de Groot PG; Hachulla E; Harlé JR; Sié P; Boffa MC
Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297
[TBL] [Abstract][Full Text] [Related]
18. Role of thrombotic and fibrinolytic disorders in osteonecrosis of the femoral head.
Lee JS; Koo KH; Ha YC; Koh KK; Kim SJ; Kim JR; Song HR; Cho SH
Clin Orthop Relat Res; 2003 Dec; (417):270-6. PubMed ID: 14646726
[TBL] [Abstract][Full Text] [Related]
19. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
20. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
